Health and Healthcare
GlaxoSmithKline Continues Down A Dangerous Path
Published:
Two more studies show that GlaxoSmithKline (GSK) blockbuster diabetes drug Avandia has significant health risks.
According to The Wall Street Journal "the Food and Drug Administration is considering whether Avandia’s use should be restricted." Studies show that the drug can increase risk of heart attack. In a research paper form Wake Forest University doctors found that patients taking Avandia had a 42% greater chance of having a heart attack than those in the control group.
The whole incident begs that question of what major drug companies never take their own products off the market when there is overwhelming evidence that they create health risk. There must be some actuary who works out the balance between profit and potential liability if court cases for wrongful death begin to emerge.
Of course, that leaves out the question of ethics.
Douglas A. McIntyre
Travel Cards Are Getting Too Good To Ignore
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
